Entecavir/rosuvastatin interactionRhabdomyolysis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1905卷 / 1期

关键词：

D O I：

10.1007/s40278-022-14597-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：207 / 207

相关论文

共 50 条

[1] Rosuvastatin/ticagrelor interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2020, 1814 (1) : 317 - 317
[2] Rosuvastatin/ticagrelor interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2017, 1676 (1) : 260 - 260
[3] Pazopanib/rosuvastatin interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2018, 1688 (1) : 185 - 185
[4] Rosuvastatin/ticagrelor interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2023, 1947 (1) : 353 - 353
[5] Rosuvastatin/tacrolimus interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2011, 1363 (1) : 36 - 36
[6] Antiretrovirals/gemfibrozil/rosuvastatin interactionRhabdomyolysis: case report
[J]. Reactions Weekly, 2011, 1364 (1) : 8 - 8
[7] Canagliflozin/rosuvastatin interactionRhabdomyolysis and hepatocellular injury: case report
[J]. Reactions Weekly, 2020, 1820 (1) : 81 - 81
[8] Rosuvastatin/warfarin interactionRhabdomyolysis followed by medication error and overdose: case report
[J]. Reactions Weekly, 2020, 1815 (1) : 292 - 292
[9] Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
Wen Wang
Xu Lu
Chengbo Li
Wei Teng
Wei Cui
[J]. BMC Infectious Diseases, 22
[10] Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
Wang, Wen
Lu, Xu
Li, Chengbo
Teng, Wei
Cui, Wei
[J]. BMC INFECTIOUS DISEASES, 2022, 22 (01)

← 1 2 3 4 5 →